CONDITIONS
Autism
Autism is a spectrum of disorders characterized by marked abnormalities in communication and social interactions. Two common, consistent findings in children with this disorder are diminished oxygenation in specific areas of the brain and a chronic immunologically mediated inflammatory condition in the gut.
The Scientific Rationale Behind Using Stem Cells To Treat Autism
The specially selected adult stem cells used to treat autism at the Stem Cell Institute come from human umbilical cord tissue (allogeneic mesenchymal). We call them Golden Cells™. Umbilical cords are donated by mothers after normal, healthy births. Before they are approved for treatment all umbilical cord-derived stem cells are screened for viruses and bacteria to International Blood Bank Standards.
Umbilical cord-derived stem cells are ideal for the treatment of autism because they allow our physicians to administer
uniform doses and they do not require any stem cell collection from the patient, which for autistic children and their parents, can be an arduous process. Because they are collected right after (normal) birth, umbilical cord-derived cells are much more potent than their “older” counterparts like bone marrow-derived cells for instance.
Cord tissue-derived mesenchymal stem cells pose no rejection risk because the body does not recognize them as foreign.
Read Dr. Riordan’s book “Stem Cell Therapy: A Rising Tide”
“Neil takes readers on a riveting journey through the past, present, and future of stem cell therapy. His well-researched, educational, and entertaining book could change your life. I highly recommend it.”
– Tony Robbins, NY Times #1 Bestselling Author
Our son is now thriving in ways I once thought would be impossible.
What are the advantages of treating autism with allogeneic umbilical cord tissue-derived stem cells?
No need to collect stem cells from the patient’s hip bone or fat under anesthesia, which especially for small children and their parents, can be an unpleasant ordeal.
There is a growing body of evidence showing that umbilical cord tissue-derived (HUCT) mesenchymal stem cells are more robust than mesenchymal stem cells from other sources.
No need to administer chemotherapy drugs like granulocyte-colony stimulating factor (G-CSF or GCSF) to stimulate the bone marrow to produce granulocytes and stem cells, and release them into the bloodstream.
Since HUCT mesenchymal stem cells are immune system privileged, cell rejection is not an issue and Human Leukocyte Antigen (HLA) matching is not necessary.
The stem cells with the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration can be screened and selected.
Allogeneic stem cells can be administered multiple times over the course of days in uniform dosages that contain high cell counts.
Umbilical cord tissue provides an abundant supply of mesenchymal stem cells.
We use Golden Cells™. Years-long retrospective analysis of patient outcomes has enabled us to identify and select the best cells for use in our patients.
Autism Treatment Protocols
One of our staff physicians will assign a stem cell treatment protocol after you have submitted all requested medical information and received approval. Your child’s recommended protocol may differ from the example given below:
- Treatment length: 6 nights
- Physical examination and blood testing: Day 1
- 4 intravenous infusions of specially selected human umbilical cord tissue-derived allogeneic mesenchymal stem cells (Golden Cells™): Days 2 – 5
Note: Includes Hilton hotel room with breakfast, WIFI, transportation from and to the airport with VIP airport gate service and expedited customs clearance upon arrival.
Mesenchymal Trophic Factors (MTF)
MTF is a next-generation, cell-free therapy derived from our proprietary Golden Cells™, designed to support healing, reduce inflammation, and promote tissue repair through a powerful blend of Exosomes and other naturally occurring molecules.
Mesenchymal Trophic Factors (or MTF) are a powerful blend of free healing molecules, extracellular vesicles, and exosomes containing modifying factors naturally released by our Golden Cells™ during their growth in the lab. This blend contains growth factors and anti-inflammatory agents that can help reduce swelling and inflammation, support the body’s healing process, and promote tissue repair.
MTF can be used independently or alongside our stem cell therapies to boost the overall benefits of our treatments. Our clinic has used the MTF on its own or in combination with our Golden Cells™ treatments for many years in conditions like arthritis, spinal cord injury, autism, age-related weakness, sports injuries, and general wellness.
- Exclusive Source: MTF comes only from our carefully selected Golden Cells™, known for their high performance in lab studies.
- Safe & Certified: Produced in our certified lab under strict international standards. Every batch is tested for quality and safety.
- Flexible Delivery: Administered via Intramuscular, Intra-articular, intranasally, and in nebulizations depending on your needs.
- More Than Exosomes: Our MTF contains not just exosomes, but also anti-inflammatory proteins, peptides, and lipids—all of which help enhance its healing power.
Early lab research shows that our MTF has strong anti-inflammatory effects, similar to a powerful medication called dexamethasone, but without the side effects.
Our Golden Cells™ derived MTF contains important healing molecules that support the body in multiple ways, including:
- PGE2 is one of the key ingredients. It helps reduce inflammation and encourages the body to switch from a “fight mode” to a “healing mode.” This allows damaged tissue to begin repairing itself.
- FGF (Fibroblast Growth Factor) supports the regeneration of many types of tissues, like skin, blood vessels, muscles, bones, nerves, and even cartilage.
- BDNF (Brain-Derived Neurotrophic Factor) is a natural protein found in the brain. It plays an important role in memory, mood, and brain function. Higher levels of BDNF may help support emotional well-being and cognitive health.
Our MTF contains the “secretome” of stem cells—an all-natural blend of healing molecules. This includes cytokines, growth factors, and tens of billions of exosomes. These molecules and exosomes have been widely studied and have been demonstrated to help as natural anti-inflammatories and regenerative therapy, they may reduce swelling, support the immune system, and promote healing in damaged tissues.
FREQUENTLY ASKED QUESTIONS
You probably have questions. We’re here to help.
No stem cell product from any source, including the patient’s own, is approved by the US FDA to treat autism.
However, human umbilical cord tissue-derived mesenchymal stem cells that were isolated and grown in our laboratory in Panama to create master cell banks have been used in the United States under US FDA regulation.
These cells served as the starting material for cellular products used in MSC clinical trials for two Duchenne’s muscular dystrophy patients under US FDA’s designation of Investigational New Drug (IND) for single-patient compassionate use. (IND 16026 DMD Single Patient).
The body’s immune system is unable to recognize umbilical cord-derived mesenchymal stem cells as foreign, and therefore they are not rejected. Human umbilical cord tissue stem cells have been administered tens of thousands of times at the Stem Cell Institute, and there has never been a single instance of rejection (graft vs. host disease). As a matter of fact, allogeneic (not the patient’s own) mesenchymal stem cells are approved to treat graft vs. host disease in Canada and New Zealand.
Umbilical cord-derived mesenchymal stem cells also proliferate/differentiate more efficiently than “older” cells, such as those found in the fat, and therefore, they are considered to be more “potent”.
The adult stem cells used to treat autism at the Stem Cell Institute come from human umbilical cord tissue (allogeneic mesenchymal). These stem cells are expanded at Medistem Panama’s state-of-the-art laboratory.
The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births. Each mother has her medical history screened and is tested for infectious diseases. Proper consent is received from each family prior to donation.
All umbilical cord-derived stem cells are screened for infectious diseases to International Blood Bank Standards before they are cleared for use in patients.
Only a small percentage of donated umbilical cords pass our rigorous screening process.
Proper follow-up is an essential part of stem cell therapy. Our primary goal is to ensure that your child is progressing safely. Regular follow-up also enables us to evaluate efficacy and improve our treatment protocols based on observed outcomes.
Therefore, our medical staff will be contacting you after 1 month, 3 months, 6 months, 9 months, and 1 year to monitor your child’s progress.
You can apply today to find out if you are eligible for treatment. You may also contact us by telephone 1 (800) 980-7836 (toll-free in US) and 1 (954) 358-3382 (International).